Abstract
The failure of protein to correctly fold into its functional and unique three dimensional form leads to misfolded or partially folded protein. When these rogue proteins and polypeptides escape the quality control mechanism within the body, they result in aberrant aggregation of proteins into characteristic amyloid fibrils. This is the main cause for the number of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s and Huntington’s diseases. This review aims to summarise the underlying mechanisms of protein folding, misfolding and aggregation. It also highlights the recent technologies for the structural characterisation and detection of amyloid fibrils in addition to the various factors responsible for the aggregate formation and the strategies to combat the aggregation process. Besides, the journey from origin to the current scenario of protein aggregation is also concisely discussed.
Keywords: Protein aggregation, anti aggregation, folding, misfolding, inhibition, amyloid fibrils, neurodegenerative diseases.
Protein & Peptide Letters
Title:Biophysical Insight into Protein Folding, Aggregate Formation and its Inhibition Strategies
Volume: 29 Issue: 1
Author(s): Syed Mohammad Zakariya, Aiman Zehra and Rizwan Hasan Khan*
Affiliation:
- Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, UP, India
Keywords: Protein aggregation, anti aggregation, folding, misfolding, inhibition, amyloid fibrils, neurodegenerative diseases.
Abstract: The failure of protein to correctly fold into its functional and unique three dimensional form leads to misfolded or partially folded protein. When these rogue proteins and polypeptides escape the quality control mechanism within the body, they result in aberrant aggregation of proteins into characteristic amyloid fibrils. This is the main cause for the number of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s and Huntington’s diseases. This review aims to summarise the underlying mechanisms of protein folding, misfolding and aggregation. It also highlights the recent technologies for the structural characterisation and detection of amyloid fibrils in addition to the various factors responsible for the aggregate formation and the strategies to combat the aggregation process. Besides, the journey from origin to the current scenario of protein aggregation is also concisely discussed.
Export Options
About this article
Cite this article as:
Zakariya Mohammad Syed , Zehra Aiman and Khan Hasan Rizwan*, Biophysical Insight into Protein Folding, Aggregate Formation and its Inhibition Strategies, Protein & Peptide Letters 2022; 29 (1) . https://dx.doi.org/10.2174/0929866528666211125114421
DOI https://dx.doi.org/10.2174/0929866528666211125114421 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Peptide Aptamers with Biological and Therapeutic Applications
Current Medicinal Chemistry Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors
Current Pharmaceutical Design Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases
Current Medicinal Chemistry Occupational Respiratory Pathology in Russia: Current Trends and Challenges
Current Respiratory Medicine Reviews Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Solid Lipid Nanoparticles (SLNs) as a Rising Tool in Drug Delivery Science: One Step Up in Nanotechnology
Current Nanoscience Bioprospecting for Functionally-Proficient Potential Probiotics
Current Nutrition & Food Science Redistribution of CD95 into the Lipid Rafts to Treat Cancer Cells?
Recent Patents on Anti-Cancer Drug Discovery Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design Organization of Carotenoids in Models of Biological Membranes: Current Status of Knowledge and Research
Current Analytical Chemistry Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Tubulin Inhibitors: A Patent Survey
Recent Patents on Anti-Cancer Drug Discovery Strategies of Functional Foods Promote Sleep in Human Being
Current Signal Transduction Therapy Nanotechnology Composites and Visual Health
Pharmaceutical Nanotechnology Tyrosyl-DNA Phosphodiesterase 1 Targeting for Modulation of Camptothecin-Based Treatment
Current Medicinal Chemistry Changes in Glutathione, Oxidative Stress and Mitochondrial Membrane Potential in Apoptosis Involving the Anticancer Activity of Cantharidin Isolated from Redheaded Blister Beetles, Epicauta hirticornis
Anti-Cancer Agents in Medicinal Chemistry Glutamate in CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition
Current Medicinal Chemistry PPARγ in Angiogenesis and Vascular Development
Current Angiogenesis (Discontinued) Targeting Cytokines, Chemokines and Adhesion Molecules in Rheumatoid Arthritis
Current Rheumatology Reviews CDK9 a Potential Target for Drug Development
Medicinal Chemistry